ライフサイエンスコーパス: biomaterial

1 ue engineering (cell migration in engineered biomaterials).

2 etofore unobserved morphology of this common biomaterial.

3 ally tested for a potential meniscal implant biomaterial.

4 t the tissues, a useful characteristic for a biomaterial.

5 agged melanin as a potential radioprotective biomaterial.

6 demonstrating its potenial as a radio-opaque biomaterial.

7 tions containing nanoparticles, polymers, or biomaterials.

8 redict the host tissue response on implanted biomaterials.

9 ween MGCs formed on the surface of implanted biomaterials.

10 r application in medicine as next-generation biomaterials.

11 ature and widely used to fabricate synthetic biomaterials.

12 bon nanotube harvester can be improved using biomaterials.

13 umor therapy based on highly innovative APDC biomaterials.

14 ew route towards artificial shear responsive biomaterials.

15 epresent building blocks for numerous useful biomaterials.

16 nts a powerful tool to study angiogenesis in biomaterials.

17 terest in the fields of drug development and biomaterials.

18 characteristics for localized NP analysis in biomaterials.

19 ssemblies could provide access to functional biomaterials.

20 and chitin, are key structural components of biomaterials.

21 of post-harvest processing for biofuels and biomaterials.

22 eed to replace native connective tissue with biomaterials.

23 he vascularization pattern and efficiency of biomaterials.

24 ic bacteria, they become food ingredients or biomaterials.

25 ing agents in both foods and a wide range of biomaterials.

26 ting the potential of AFMIR to study complex biomaterials.

27 characteristics and behavior of scaffolding biomaterials.

28 hallenging because of the lack of satisfying biomaterials.

29 g support for the importance of chirality in biomaterials.

30 r, is required for FBGC formation and FBR to biomaterials.

31 AFB(1) was well adsorbed by the three tested biomaterials (70 to 100%).

32 T analysis demonstrated that the cell-seeded biomaterial achieved significantly more bone volume form

33 d form a nanoparticle-assembled porous solid biomaterial after freezing and lyophilization treatment.

34 Biomaterial-aided mandibular reconstruction was successf

35 duced macrophage fusion, we examined whether biomaterial alone can initiate and control the fusion ra

36 can be used to construct functional hydrogel biomaterials-an attractive approach for neural tissue en

37 rk on the application of THz spectroscopy to biomaterial analyses on increasing scales, targeting DNA

38 translational potential have been limited by biomaterial and culture media compositions, as well as c

39 ticles (GNPs) could assemble to form a solid biomaterial and whether this solid biomaterial was capab

40 ng blocks has been pursued toward artificial biomaterials and advanced functional materials.

41 The rapid vascularisation of biomaterials and artificial tissues is a key determinant

42 The structural complexity of composite biomaterials and biomineralized particles arises from th

43 Advanced biomaterials and drug delivery systems, such as nanopart

44 Technologies such as batteries, biomaterials and heterogeneous catalysts have functions

45 dy reaction reflects the integration between biomaterials and host cells.

46 g mucosal vaccination, particularly aided by biomaterials and mechanistic immune-material interaction

47 Foreign body reaction (FBR) to implanted biomaterials and medical devices is common and can compr

48 sue integration and performance of implanted biomaterials and medical devices.

49 centered around blood protein adsorption on biomaterials and related mechanisms of thrombus formatio

50 ering, anti-fouling coating, and implantable biomaterials and sensors.

51 imulation of therapeutics in vivo using nano-biomaterials and soft bioelectronic devices provide grea

52 s and silk proteins serve as edible photonic biomaterials and the photoluminescent properties provide

53 ew aims at a classification of agarose-based biomaterials and their derivatives applicable for contro

54 tion and critical evaluation of contemporary biomaterials and their specific roles in bioprinting mic

55 lity tests are needed in the pharmaceutical, biomaterial, and environmental industries to measure adv

56 or their potential applications in medicine, biomaterials, and biotechnology.

57 e of heparinized biomaterials, prostaglandin biomaterials, and block copolymer systems.

58 planning, nanotechnology, materials science, biomaterials, and clinical informatics.

59 encoding and combining functions of optics, biomaterials, and environmental interfaces in a single d

60 trical barrier coatings, photonic materials, biomaterials, and pharmaceutical oral drug delivery.

61 recise placement of living cells, functional biomaterials, and programmable release capsules.

62 ructures have great potentials in functional biomaterials, and yet the tedious and costly covalent pe

63 Oligo- and polysaccharides-based biomaterials are being developed to mimic the glycocalyx

64 healing and macrophage response to implanted biomaterials are discussed with the vision of applying t

65 enable the design of the next generation of biomaterials are discussed.

66 However, polymeric biomaterials are lacking imaging contrast properties for

67 Protein-based structural biomaterials are of great interest for various applicati

68 evelopment of GQDs as novel, multifunctional biomaterials are presented with a focus on their physico

69 The hybrid photosynthetic biomaterials are produced with a 3D bioprinting platform

70 However, few biomaterials are suitable for use as long-term implants

71 Biomaterials are valuable resources to support this goal

72 ication of natural, synthetic, and composite biomaterials as 3D printed hydrogels.

73 found in nature as an inspiration to design biomaterials as promising diagnostic tools, therapeutic

74 ering and biological principles of designing biomaterials as separate topics, which has resulted in n

75 The growing role of biomaterials as tools to dissect immune function in fund

76 contributions from both biochemical cues and biomaterials as well as the means of harmonizing them.

77 Importantly, the implanted islet-seeded biomaterial assembled into a solid organoid substructure

78 The biomaterial-assisted sequestration of adenosine leverage

79 Herein, biomaterial-assisted sequestration of small molecules is

80 ns, efforts have been made to create central biomaterial banks and catalogues.

81 recise spatiotemporal placement of cells and biomaterials based on computer-aided design.

82 Biomaterial-based AML vaccination can induce potent immu

83 Advanced therapies which combine cells with biomaterial-based carriers are recognized as an emerging

84 mor detection markers, biosensors, and other biomaterial-based devices.

85 Using a novel biomaterial-based drug delivery system in the form of a

86 We describe the use of engineered biomaterial-based immunological niches amenable to biops

87 distributed format that relies on the use of biomaterial-based inks to print and stabilize determinis

88 n of applying these principles to localized, biomaterial-based modulation of tumor-associated macroph

89 Finally, an outlook is given of how future biomaterial-based mucosal cancer vaccines will be shaped

90 reactors against rib periosteum and utilized biomaterial-based space maintenance to preserve the nati

91 nt biological responses are needed to design biomaterial-based therapies with improved outcomes in th

92 The biomaterial-based vaccine prevented the engraftment of A

93 ations are described regarding the design of biomaterial-based vaccines that will afford antitumor im

94 This biomaterials-based approach generates 2D diffractive opt

95 xide (GO) and its derivatives as a potential biomaterial because of their attractive physicochemical

96 s in synthesis and fabrication of structural biomaterials by DNA recombinant technology and chemical

97 ion of proteins) to create a class of hybrid biomaterials called cholesterol-modified polypeptides (C

98 Biomaterials can improve the safety and presentation of

99 rboring chambers and large vessels with soft biomaterials, can be achieved using 3-dimensional biopri

100 biomolecules/functional units, imaging smart biomaterials capable of sensing, interacting, delivery a

101 chirality in biological systems, controlling biomaterial chirality to influence interactions with cel

102 this association, we capitalized upon a rare biomaterials collection of newborn CSF samples to conduc

103 ogenic factors, within a mechanically-strong biomaterial combined during manufacturing would replace

104 Specifically, a synthetic biomaterial containing boronate molecules is designed to

105 More importantly, this solid biomaterial could undergo solid-to-hydrogel transition a

106 ular tractions within three-dimensional (3D) biomaterials could elucidate collective dissemination du

107 c mice upon implantation of the islet-seeded biomaterial coupled with reduced blood glucose levels, c

108 ineering approaches, including the design of biomaterials, delivery strategies and nanotechnology sol

109 These results suggest that the biomaterial-derived stimuli exert similar functions as c

110 Nanoclays have generated interest in biomaterial design for their ability to enhance the mech

111 y elegant model that also has application in biomaterial design.

112 their environment, leading to strategies for biomaterial design.

113 ok on the challenges facing the evolution of biomaterials design for bioprinting microvasculature wit

114 ion, and mutation results in optimization of biomaterials designs.

115 ng a wide range of bio applications, such as biomaterials, drug delivery, biomedicine, biotherapy and

116 direct inclusion of growth factors with the biomaterial during printing, or intermediary encapsulati

117 early efforts contributed directly to Utah's biomaterials efforts and the Total Artificial Heart prog

118 ased on a combinatorial nano-engineering and biomaterial encapsulation approach, could therefore offe

119 Here, we demonstrate that biomaterial encapsulation into alginate using a microflu

120 lay' platform will be expanded towards smart biomaterial engineering for therapeutic delivery, precis

121 Photochemical ligation is important in biomaterials engineering for spatiotemporal control of b

122 our method can contribute to development of biomaterials engineering that has been limited by the re

123 ng interest in the development of functional biomaterials, especially hydrogels, for utilization in t

124 es, xenotransplantation studies, and in vivo biomaterials evaluation.

125 BCP and beta-TCP biomaterials exhibited a synergic effect with rhBMP-2/AC

126 vides a fundamental principle for functional biomaterials exhibiting multifaceted stimuli on differen

127 Potential biomaterials exploiting the CH-pai bond-based stabilizat

128 culate how engineering strategies, including biomaterial fabrication and templating, might be used to

129 nting surface optical structures onto chiral biomaterials facilitates a range of prospective photonic

130 We found that biomaterial FBRs mimic specialized multicellular CNS wou

131 A common theme is exploiting biomaterial features to rationally direct how specific i

132 t the Duragen Plus(TM) matrix is a promising biomaterial for delivery of stem cell transplant populat

133 D-printed hydroxyapatite-based scaffold as a biomaterial for obtaining guided bone regeneration (GBR)

134 ovelty, simplicity and effectiveness of this biomaterial for tissue regeneration and in vivo restorat

135 chemical properties mark them as a candidate biomaterial for various applications, yet difficulties i

136 c responses of ECs and can be developed as a biomaterial for vascularization.

137 Here, the role of biomaterials for applications in tissue regeneration, th

138 delivery systems and implantable drug loaded biomaterials for brain repair are among some of these la

139 operties make laminin peptide-ELPs promising biomaterials for cell culture and tissue engineering.

140 means for generating more effective and safe biomaterials for cell replacement therapies.

141 Encapsulated delivery of stem cells in biomaterials for cell therapy is gaining popularity but

142 ortant implications for developing effective biomaterials for CNS applications.

143 NA and their hybrids with DNA as alternative biomaterials for constructing tension sensors.

144 The ever-growing use of agarose-based biomaterials for drug delivery systems resulted in rapid

145 This unexpected use of biomaterials for early detection of cancer provides a mo

146 The development of novel brain-specific biomaterials for generating mature in vitro brain models

147 eralization and improve design strategies of biomaterials for medical applications.

148 portunities, and challenges of piezoelectric biomaterials for medical uses are reviewed thoroughly.

149 sel architecture is critical when validating biomaterials for regenerative medicine purposes and requ

150 disorders remain limited, owing to a lack of biomaterials for sensing and modulating neuronal signall

151 Ideal biomaterials for T/L repair and regeneration need to pos

152 ular gels have recently emerged as promising biomaterials for the delivery of a wide range of bioacti

153 e is great interest in developing conductive biomaterials for the manufacturing of sensors or flexibl

154 for the development of structurally dynamic biomaterials for therapeutic hydrogel delivery to the MI

155 ndidate polymers to engineer low immunotoxic biomaterials for various biomedical studies.

156 ruct autologous jejunal mucosal grafts using biomaterials from pediatric patients and show that patie

157 vivo, or about how such responses influence biomaterial function.

158 This modular and versatile biomaterial functionalization platform can provide new o

159 eceptor eluting gelatin methacryloyl (GelMA) biomaterials (GelMA/anti-IL-6), which were implanted at

160 d at 8 weeks, in opposition to the acellular biomaterial group.

161 rst successful in vivo application of such a biomaterial-guided delivery of a potent gene vector in a

162 Advanced biomaterial-guided delivery of gene vectors is an emergi

163 Many biomaterials have been developed which aim to match the

164 These biomaterials have drawn increasing attention in recent y

165 Recent developments in tunable biomaterials have helped identify how extracellular matr

166 Furthermore, Si-containing bioactive glass biomaterials have positive effects on bone regeneration

167 Biomaterials have the potential to extend the therapeuti

168 Thus, GNP-assembled solid biomaterials hold great potential as an off-the-shelf th

169 Biomaterials hold promise for therapeutic applications i

170 Among a variety of natural and synthetic biomaterials, hyaluronate (HA) has been considered a pro

171 Group 1: biomaterial hydrated in blood; Group 2: biomaterial hydr

172 p 1: biomaterial hydrated in blood; Group 2: biomaterial hydrated in physiologic saline.

173 omonas aeruginosa), the most common cause of biomaterial implant failure in modern medicine.

174 ion as well as their drug sensitivity in the biomaterial implanted tissue environment.

175 Synthetic biomaterials implanted in the body induce a foreign body

176 f Cancer Research, Oakes and colleagues used biomaterial implants and their associated immunologic ac

177 Immune dynamics at biomaterial implants, functioning as a synthetic metasta

178 foreign body giant cells, to respond to the biomaterial implants.

179 nd struts dimension, the selection of proper biomaterials improve the follicles adhesion and developm

180 se and controlled layer-by-layer assembly of biomaterials in a desired 3D pattern.

181 which is one of the most abundant renewable biomaterials in nature.

182 d describe the potential use of viscoelastic biomaterials in regenerative medicine.

183 e future developments ahead of agarose-based biomaterials in the realm of advanced drug delivery.

184 AMs are highlighted, emphasizing the role of biomaterials in these approaches.

185 To understand the biomaterial-induced macrophage fusion, we examined wheth

186 rome, preeclampsia, sickle cell disease, and biomaterial-induced thromboinflammation.

187 od properties important to the bioenergy and biomaterial industries.

188 While the effect of biomaterial injection in reducing mechanical wall stress

189 Biomaterial injection is a novel therapy to treat ischem

190 Our results suggest that biomaterial injection therapy does not affect the region

191 ophysiological vulnerability associated with biomaterial injection therapy.

192 Novel biomaterial inks used for the formation of bioinks have

193 re important to consider for translating new biomaterials into clinical practice are highligted.

194 caffolds via robotic deposition of cells and biomaterials into custom shapes and patterns to replicat

195 on to sequestering endogenous adenosine, the biomaterial is also able to deliver exogenous adenosine

196 acteria into microcapsules using appropriate biomaterials is a promising approach for reducing cell d

197 ible, and biocompatible silk-based composite biomaterials is demonstrated.

198 The success of host responses to biomaterials, known as biocompatibility, depends on chem

199 SCTG, CAF alone or associated with another biomaterial may be used for treating single or multiple

200 bacterial cells, and suggest how such novel biomaterials may be exploited in future studies.

201 transportation (tires, gaskets, and seals), biomaterials, microcontact printing, and soft robotics.

202 arious technological areas, such as advanced biomaterials, morphologically defined soft matter or the

203 has led to a new class of oxygen-generating biomaterials, most reported techniques lack the tunabili

204 Undoubtedly, this class of biomaterials needs further advancement, and a lot of cri

205 n graphite oxide, platinum nanoparticles and biomaterials obtained from Botryosphaeria rhodina MAMB-0

206 Well-characterized biomaterials of high quality have great potential for ac

207 ay nanomaterials are an emerging class of 2D biomaterials of interest due to their atomically thin la

208 been recently demonstrated, the influence of biomaterials on the electrical behavior of treated heart

209 ing genetic engineering and integration with biomaterials or drug delivery systems, is examined.

210 properties of a cell's microenvironments on biomaterials or within tissue engineering constructs.

211 ly bind the Imi-peptides onto nanoparticles, biomaterials, or diagnostic probes.

212 will lead to novel strategies for designing biomaterials organized at and interfaced with inorganic

213 important implications for use of xenogeneic biomaterials, particularly in vascular applications.

214 It is demonstrated that implantation of the biomaterial patch following injury establishes an in sit

215 n the development of thermostable, colorfast biomaterial pigments.

216 However, the lack of a biomaterial platform which allows the facile manipulatio

217 th subcutaneous tissues than the widely used biomaterial-polycaprolactone.

218 om 2D assemblies to peptide amphiphile-based biomaterials, Prof.

219 hemical properties, and/or poor stability of biomaterial properties after implantation.

220 f the non-thrombogenic nature of heparinized biomaterials, prostaglandin biomaterials, and block copo

221 a intact, seems promising to provide optimal biomaterial protection and healing conditions, even when

222 se of the gap between the tiny quantities of biomaterials provided by a clinical sample and the large

223 becular connectivity was diminished when the biomaterials received rhBMP-2/ACS.

224 in fields as varied as structural materials, biomaterials, rheology modifiers, construction, paper en

225 he development of an inflammation modulating biomaterial scaffold (bioscaffold) for soft tissue repai

226 gineering strategies enable the seeding of a biomaterial scaffold and subsequent implantation to cons

227 A synthetic biomaterial scaffold can function as a synthetic metasta

228 O(2)) technology for manufacturing a "smart" biomaterial scaffold, which retains the native protein c

229 Biomaterial scaffolds have served as the foundation of t

230 Biomaterial scaffolds that are designed to incorporate d

231 ase, we report first-generation poly(pro-E2) biomaterial scaffolds that release E2 at nanomolar conce

232 ional (3D) cultures (i.e. pellets and seeded biomaterial scaffolds) in vitro; however, these construc

233 fibrillar collagen deposition in vivo and in biomaterial scaffolds, but the cell-signaling events tha

234 ies focus on the development of vascularized biomaterial scaffolds.

235 eneration involve a combination of cells and biomaterial scaffolds.

236 icroelectronics, nanotechnology and advanced biomaterial science.

237 and functioning microstructures, advances in biomaterials science that have enabled this progress, th

238 oad range of applications in nanotechnology, biomaterials science, nanomedicine and healthcare, as ad

239 or several human diseases, biotechnology and biomaterial sciences.

240 port that a newly developed cationic polymer biomaterial serves as an efficient bioscaffold for deliv

241 nologies, microfluidics, advanced materials, biomaterials, smart systems, photonics, robotics, textil

242 We found the biomaterial-stimuli interacted regional macrophages and

243 Several biomaterials strategies to improve healing of these tiss

244 onents of the devices, including constituent biomaterials, structural layouts, assembly methods, and

245 ll as other delivery challenges into various biomaterials such as bones.

246 these studies utilized clinically available biomaterials, such as bone cement and ceramic particles,

247 n also induce damage and fracture in natural biomaterials, such as bone, and in synthetic biomaterial

248 Additionally, advances in biomaterials, such as shape-memory foams, biodegradable

249 olume (MicroCT) strongly correlated for both biomaterials, suggesting that our approach allows for a

250 Herein, we review the development of biomaterials suited for light-based 3D printing modaliti

251 l signaling pathways in the body and how the biomaterial surface is designed.

252 and physical interactions between cells and biomaterial surface.

253 Advances in biomaterial synthesis and fabrication, stem cell biology

254 nterest in various emerging fields for novel biomaterial synthesis.

255 elaxation of stress are typically coupled in biomaterial systems used to explore these effects, makin

256 In this review, we present biomaterials systems capable of spatially and temporally

257 successfully integrated into the electrospun biomaterial that resulted in a differential release prof

258 S(2)) nanomaterials are an emerging class of biomaterials that are photoresponsive at near-infrared w

259 "Smart" biomaterials that are responsive to physiological or bio

260 rtunities towards the design of implants and biomaterials that can be personalized, and exhibit enhan

261 ntial for expanding the form and function of biomaterials that can be realized.

262 everal research groups are exploring various biomaterials that can prolong the half-life, increase st

263 oxygen sensing of other cell populations and biomaterials that change over time to better understand

264 ith the goal of building the next-generation biomaterials that combine the advantages of FNA and nano

265 ith the goal of building the next-generation biomaterials that combine the advantages of FNAs and nan

266 Stimuli-responsive biomaterials that contain logic gates hold great potenti

267 allenges facing the development of printable biomaterials that promote robust formation and controlle

268 The fabrication of dynamic, transformable biomaterials that respond to environmental cues represen

269 2D layers without the help of any supporting biomaterial, the obtainment of more complex 3D architect

270 n intermediary between cells and scaffolding biomaterials, the extracellular matrix secreted by the c

271 n is devoted to the design and validation of biomaterials, the nature of their interactions with the

272 ent- or healthy-individual-derived cells and biomaterials through 3D bioprinting technologies potenti

273 and growth factors site-specifically to gel biomaterials through a photocleavable protein (PhoCl) th

274 f preconditioning or priming the capacity of biomaterials through cell-material interactions.

275 veraging current advances in fabrication and biomaterials to create implantable devices that generate

276 his will have ramifications in the design of biomaterials to enhance therapeutic applications of stem

277 of patient-specific cells or with precision biomaterials to guide cellular activity in response to t

278 mental compositions of GBM and BBB, relevant biomaterials to mimic the native tissues, and bioprintin

279 r inform the design and translation of novel biomaterials to promote their regeneration.

280 Bovine pericardium (BP) is a vascular biomaterial used in cardiovascular surgery that is typic

281 the ability of Duragen Plus(TM) - a clinical biomaterial used widely in neurosurgical duraplasty proc

282 anical properties are key components of many biomaterials used for regenerative medicine and drug del

283 mly into four groups of two animals based on biomaterials used for treatment: 1) received no treatmen

284 biomaterials, such as bone, and in synthetic biomaterials used in implant devices.

285 se models of AML, we show that a macroporous-biomaterial vaccine that delivers the cytokine granulocy

286 Histology confirmed that the cell-seeded biomaterial was almost completely substituted at 8 weeks

287 m a solid biomaterial and whether this solid biomaterial was capable of transforming into a hydrogel

288 Resorption rate of the remaining biomaterial was improved by rhBMP-2/ACS, mainly in BBM (

289 er, the friction properties of the exemplary biomaterial were also higher, when tested under dynamic

290 We expect that these sugar-based soft biomaterials will have applications beyond supramolecula

291 ys and engineering principles of designing a biomaterial with an emphasis on its surface physicochemi

292 DNA is a versatile biomaterial with well-defined mechanical and biochemical

293 omising solution would be the development of biomaterials with both significant regenerative potentia

294 This work sheds novel insight into designing biomaterials with heterogeneous nano-ligand sequences at

295 s, lack of reliable techniques for designing biomaterials with optimal physicochemical properties, an

296 the findings could be used in the design of biomaterials with physiologically relevant mechanical pr

297 rst step towards next-generation implantable biomaterials with prolonged release and excellent regene

298 nanostructures creates an important class of biomaterials with robust mechanical properties and impro

299 design these hybrid peptide-oligonucleotide biomaterials with the desired sequence sensitivity and d

300 design guidelines for the next generation of biomaterials, with the goal of matching tissue and ECM m